The Tirzepatide program at Hawaii Wellness Clinic is particularly well suited for patients who have a BMI of 30 or greater, or 27 or greater with weight-related health conditions, have tried semaglutide or other GLP-1 medications without achieving adequate results, have significant insulin resistance, metabolic syndrome, or type 2 diabetes requiring stronger metabolic intervention, need more powerful appetite suppression to manage persistent hunger and cravings, are seeking the most aggressive non-surgical, medically supervised weight loss results currently available, or want to address substantial cardiovascular risk factors such as elevated triglycerides, low HDL, and elevated blood sugar alongside weight loss
L-Carnitine is the direct, biologically superior choice for active weight loss
People who combine physical activity with their GLP-1 weight loss protocol often find that bupropion energizing effect makes exercise more accessible than it was before treatment
Anti-atherogenic and anti-inflammatory properties of glucagon-like peptide-1, glucose-dependent insulinotropic polypepide, and dipeptidyl peptidase-4 inhibitors in experimental animals
